U.S. Colorectal Cancer Screening Market Unlocking Growth Opportunities: Analysis and Forecast 2024-2032

Key Insights

The U.S. Colorectal Cancer Screening Market size was valued at USD 10.38 USD Billion in 2023 and is projected to reach USD 14.13 USD Billion by 2032, exhibiting a CAGR of 4.5 % during the forecast period. Colon cancer screening utilizes different methods that are meant to detect not only the precancerous polyps but also the cancerous growths in the colon and rectum. Approaches like colonoscopy, sigmoidoscopy, FOBT (fecal occult blood tests), FIT (fecal immunochemical tests), and stool DNA tests are the methods of this section. Every type of screening has its own set of pros: it may be highly or low invasive, accurate, and/or performed very rarely or frequently. They tend to focus at the early stages, and preventive measures; in turn, they are very effective in reducing mortality rates. In the US market, current trends show consumers are now opting to use FIT and stool DNA tests mainly because the less-invasive tests are painless and deliver optimal results alongside improvements in technology which has resulted in tests that are accurate and affordable thus ensuring these tests are widely adopted and continue to improve patient outcomes. 

U.S. Colorectal Cancer Screening Trends

• Growing adoption of non-invasive screening methods
• Increasing use of AI-powered screening tools
• Rising focus on personalized screening approaches

Driving Forces:

• Rising Prevalence of Colorectal Cancer: Growing incidence of colorectal cancer due to factors such as sedentary lifestyle, unhealthy diet, and aging population.
• Increased Awareness: Heightened awareness about the benefits of early detection and screening through public health campaigns and initiatives.
• Technological Advancements: Development of advanced screening technologies, such as AI-powered analysis and non-invasive procedures, improving detection rates.

Challenges and Restraints

• Discomfort and invasiveness of traditional screening methods
• Lack of awareness about screening guidelines
• Cost of screening procedures

Emerging Trends

• Point-of-Care Screening: Development of rapid and accurate point-of-care screening tests for increased accessibility.
• Liquid Biopsy: Utilization of blood or saliva samples for colorectal cancer detection, offering non-invasive screening options.
• Personalized Screening: Adoption of tailored screening strategies based on individual risk factors and genetic markers.

Growth Catalysts

• Government Initiatives: Implementation of national screening programs and campaigns to increase public awareness and access to screening.
• Reimbursement Coverage: Favorable reimbursement policies for screening procedures, making them more accessible to patients.
• Research and Development: Ongoing research and development efforts to improve screening techniques and diagnostic tools.

Market Segmentation

Type:

• Stool-based (Fecal Immunochemical Test (FIT), Fecal Occult Blood Test (FOBT))
• Colonoscopy
• Sigmoidoscopy
• Virtual Colonoscopy

End-user:

• Hospitals & Clinics
• Clinical Laboratories
• Diagnostic Imaging Centers
• Others

Leading Players

• Exact Sciences Corporation (U.S.)
• Epigenomics AG (Germany)
• bioMérieux, Inc. (France)
• Olympus Corporation (Japan)
• KARL STORZ SE & Co. KG (Germany)
• EIKEN CHEMICAL CO., LTD.
• FUJIFILM Holdings America Corporation
• Clinical Genomics Technologies Pty Ltd. (U.S.)

Comprehensive Coverage U.S. Colorectal Cancer Screening Market Report

The comprehensive report includes the following:

• Market Size and Forecasts: Detailed analysis of the current market size and projections for future growth, segmented by screening methods, regions, and key submarkets.
• Trend and Driver Analysis: Identification and evaluation of market trends and drivers shaping the U.S. colorectal cancer screening landscape, including technological advancements, regulatory changes, and public health initiatives.
• Growth Opportunity Assessment: Exploration of key growth opportunities in emerging segments, innovative technologies, and untapped markets.
• Competitive Landscape Assessment: Comprehensive analysis of major market players, their market share, product offerings, and strategic initiatives.
• SWOT Analysis: In-depth SWOT analysis of key market players, highlighting their strengths, weaknesses, opportunities, and threats.
• Company Profiles: Detailed profiles of leading companies in the market, providing insights into their business strategies, financial performance, and market positioning.
• Industry Developments: Tracking of the latest industry developments, such as mergers and acquisitions, product launches, and regulatory updates.
• Regional Insights: Granular analysis of market dynamics and opportunities in key regions within the United States, including geographic segmentation and growth projections.

Import and Export Analysis

The report provides an in-depth analysis of the U.S.'s import and export activities related to colorectal cancer screening products and services.

Patent/Trademark Analysis

The report includes a detailed examination of the intellectual property landscape in the U.S. colorectal cancer screening market.